EWA
IMMU

Evolution Wealth Advisors’s Immunomedics Inc IMMU Stock Holding History

Evolution Wealth Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-579
Closed -$12K – 681
2019
Q4 		$12K Buy
579
+523
+934% +$9.23K ﹤0.01% 276
2019
Q3 		$1K Sell
56
-555
-91% -$8.16K ﹤0.01% 475
2019
Q2 		$8K Buy
+611
New +$9.19K ﹤0.01% 202

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Evolution Wealth Advisors's IMMU Position: Q1 2020 in Review

Evolution Wealth Advisors sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 579 shares — an estimated $12K sold.

Evolution Wealth Advisors first reported a position in IMMU in Q2 2019 and held it in 3 quarters. The position peaked at $12K in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Evolution Wealth Advisors reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Evolution Wealth Advisors sold 579 Immunomedics Inc shares in Q1 2020, an estimated $12K.
  • Evolution Wealth Advisors first reported a position in Immunomedics Inc in Q2 2019 and held it in 3 quarters.
  • Evolution Wealth Advisors's Immunomedics Inc position peaked at $12K in Q4 2019.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Evolution Wealth Advisors's 13F filing for Q1 2020, filed 22 Apr 2020.